Evolving Treatment Strategies in High-Risk Neuroblastoma - Episode 1
An Overview of Neuroblastoma
Giselle Sholler, MD, provides an overview of neuroblastoma, highlighting that 50% of all diagnosed cases in the US are considered high-risk, with a relapse rate of over 40%.
